Medical movies made about the world’s top medical conditions are more expensive than they are worth, according to a study released Monday.
The study, by the RAND Corporation, found the average movie ticket for the top 20 movies in the top 25 genres had an average retail price of $5,872, up from $3,836 in the previous study.
The average film ticket for a top 25 film in the bottom 25 genres has an average of $2,818, up slightly from $2.842.
The researchers said this discrepancy is likely due to differences in the market for the movies themselves, including whether they were released in theaters, online, or digital platforms.
But the study’s authors also noted that movies tend to be cheaper in different countries and in different states, which can lead to higher average prices in different places.
The RAND study, which surveyed 1,200 people who purchased tickets to about 1,800 movies, found that about half the films featured people who were alive at the time of the movie’s release, while the other half were only featured in the last five years of the movies’ theatrical run.
The median age of the top movies in each category was 52.5, while that of the bottom films was 34.5.
That means that the average ticket price for the most expensive movies is about $6,000.
That compares to an average price of about $2 to $3 per ticket for movies that are not in theaters.
The biggest difference between the top and bottom movies is in the way that they were produced.
The top movies typically featured a team of scientists who conducted research that helped inform the movie, with a median age at the film’s inception of 62 years old, according the study.
For the bottom 50 films, the median age was only 46.6.
The other big difference is the way the films were distributed, with the top 50 movies averaging about 75% of their gross domestic box office, while those that were in the lower 50 percent were typically distributed through smaller distribution channels.
For example, the top 5 movies averaged about 40% of the total gross, while all the bottom movies averaged just 13%.
This means that when a movie is released in the United States, it’s generally distributed through a big, well-known distribution company that has a lot of money behind it, the researchers said.
The findings are the first to document the differences in prices between films that feature people who are alive at launch, and films that are featured in an earlier period.
They also suggest that it’s not a matter of whether or not the movies were made in the U.S. or in another country.
The authors said the study “has important implications for the publics understanding of the relative value of the health benefits of medical movies.”
The researchers also say that the results do not necessarily mean that people who purchase tickets to the most popular films in a particular genre should feel pressured to pay higher prices.
“The results should not be taken as implying that people should purchase less expensive medical movies,” they wrote.
“Rather, they should seek to balance the relative costs of the medical movies with the costs of attending other entertainment options.”
A spokesperson for the Motion Picture Association of America said the association has “no position on the validity of the RAND study.”
